Fore Biotherapeutics Funding & Investors

Philadelphia, PA

Fore Biotherapeutics is a precision oncology company rooted in science and innovation, developing cancer therapies guided by functional genomics.

Total Amount Raised: $166,500,000

Series D
$75,000,000
Aug 22, 2023
Series D Investors
Medicxi
Sr One
Cormorant Asset Management
Samsung Securities Co.
3B Future Health Fund
OrbiMed Advisors
Wellington Management
Novartis Venture Fund
HBM Partners
Series C
$57,000,000
Sep 20, 2020
Series C Investors
Pontifax
Cormorant Asset Management
HBM Healthcare Investments
Sr One
Wellington Management
OrbiMed Advisors
Novartis Venture Fund
Series Unknown
$6,000,000
Apr 29, 2018
Series Unknown Investors
SICAR
Bio Capital Impact Fund
Windham Venture Partners
3B Future Health Fund
Series Unknown
$2,500,000
Jun 21, 2016
Series Unknown Investors
OrbiMed Advisors
Series Unknown
$10,000,000
Dec 22, 2015
Series Unknown Investors
InterCure
Seed
$8,000,000
Jun 30, 2014
Seed
$8,000,000
Jun 30, 2013

Funding info provided by Diffbot.